France Clinical Chemistry Market Outlook to 2024

Published : Nov-2017

No. of Pages : 97

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Clinical Chemistry Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 8
3 Clinical Chemistry Market, France 13
3.1 Clinical Chemistry Market, France, Revenue ($m), 2010-2017 13
3.2 Clinical Chemistry Market, France, Revenue ($m), 2017-2024 15
3.2.1 Blood Test Strips - Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2010-2017 17
3.2.2 Clinical Chemistry Analyzers Market, France, Revenue ($m), by Segment, 2010-2017 19
3.2.3 Enzyme Chemistry Reagents Market, France, Revenue ($m), by Segment, 2010-2017 21
3.2.4 Feces Tests - Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2010-2017 23
3.2.5 Substrates Market, France, Revenue ($m), by Segment, 2010-2017 25
3.2.6 Therapeutic Drug Monitoring Market, France, Revenue ($m), by Segment, 2010-2017 27
3.2.7 Urine Analysis Market, France, Revenue ($m), by Segment, 2010-2017 29
3.2.8 Urine Testing - Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2010-2017 31
3.2.9 Blood Test Strips - Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2017-2024 33
3.2.10 Clinical Chemistry Analyzers Market, France, Revenue ($m), by Segment, 2017-2024 35
3.2.11 Enzyme Chemistry Reagents Market, France, Revenue ($m), by Segment, 2017-2024 37
3.2.12 Feces Tests - Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2017-2024 39
3.2.13 Substrates Market, France, Revenue ($m), by Segment, 2017-2024 41
3.2.14 Therapeutic Drug Monitoring Market, France, Revenue ($m), by Segment, 2017-2024 43
3.2.15 Urine Analysis Market, France, Revenue ($m), by Segment, 2017-2024 45
3.2.16 Urine Testing - Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2017-2024 47
3.3 Clinical Chemistry Market, France, Volume (Units), 2010-2017 49
3.4 Clinical Chemistry Market, France, Volume (Units), 2017-2024 51
3.4.1 Blood Test Strips - Rapid Tests & POC Market, France, Volume (Units), by Segment, 2010-2017 53
3.4.2 Clinical Chemistry Analyzers Market, France, Volume (Units), by Segment, 2010-2017 55
3.4.3 Enzyme Chemistry Reagents Market, France, Volume (Units), by Segment, 2010-2017 57
3.4.4 Feces Tests - Rapid Tests & POC Market, France, Volume (Units), by Segment, 2010-2017 59
3.4.5 Substrates Market, France, Volume (Units), by Segment, 2010-2017 61
3.4.6 Urine Testing - Rapid Tests & POC Market, France, Volume (Units), by Segment, 2010-2017 63
3.4.7 Blood Test Strips - Rapid Tests & POC Market, France, Volume (Units), by Segment, 2017-2024 65
3.4.8 Clinical Chemistry Analyzers Market, France, Volume (Units), by Segment, 2017-2024 67
3.4.9 Enzyme Chemistry Reagents Market, France, Volume (Units), by Segment, 2017-2024 69
3.4.10 Feces Tests - Rapid Tests & POC Market, France, Volume (Units), by Segment, 2017-2024 71
3.4.11 Substrates Market, France, Volume (Units), by Segment, 2017-2024 73
3.4.12 Urine Testing - Rapid Tests & POC Market, France, Volume (Units), by Segment, 2017-2024 75
3.5 Clinical Chemistry Market, France, Average Price ($), 2010-2024 77
3.6 Clinical Chemistry Market, France, Distribution Share by Revenue ($m), 2017 81
3.7 Clinical Chemistry Market, France, Company Share by Revenue ($m), 2017 82
4 Overview of Key Companies in France, Clinical Chemistry Market 84
4.1 F. Hoffmann-La Roche Ltd 84
4.1.1 Company Overview 84
4.2 Siemens Healthcare GmbH 84
4.2.1 Company Overview 84
4.3 Ortho-Clinical Diagnostics Inc 84
4.3.1 Company Overview 84
4.4 Beckman Coulter Inc 84
4.4.1 Company Overview 84
4.5 Abbott Laboratories 85
4.5.1 Company Overview 85
4.6 bioMerieux SA 85
4.6.1 Company Overview 85
4.7 Thermo Fisher Scientific Inc 85
4.7.1 Company Overview 85
4.8 Horiba Ltd 85
4.8.1 Company Overview 85
4.9 Orion Diagnostica Oy 86
4.9.1 Company Overview 86
4.10 Alere Inc 86
4.10.1 Company Overview 86
4.11 PTS Diagnostics 86
4.11.1 Company Overview 86
5 Clinical Chemistry Market Pipeline Products 87
6 Financial Deals Landscape 89
6.1 Private Equity 89
6.1.1 PAI Partners to Acquire ELITech from Ergon Capital Partners 89
7 Recent Developments 90
7.1 Product News 90
7.1.1 Jul 19, 2017: HISTALIM Will Develop Its Own Precision Medicine Tool Named HISTOPROFILE Through a Collaborative R&D Program of 29 Million Euros, Endorsed by BPIfrance 90
8 Appendix 91
8.1 Research Methodology 92
8.1.1 Coverage 92
8.1.2 Secondary Research 92
8.1.3 Primary Research 93
8.1.4 Market Modeling and Forecasting 94
8.1.5 Company Share Analysis 95
8.1.6 Distribution Share Analysis 96
8.1.7 Benchmarking 96
8.2 GlobalData Consulting 96
8.3 Contact Us 97
8.4 Disclaimer 97

1.1 List of Tables
Table 1: Clinical Chemistry Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 14
Table 2: Clinical Chemistry Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 16
Table 3: Blood Test Strips - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 18
Table 4: Clinical Chemistry Analyzers Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 20
Table 5: Enzyme Chemistry Reagents Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 22
Table 6: Feces Tests - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 7: Substrates Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 8: Therapeutic Drug Monitoring Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 28
Table 9: Urine Analysis Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 30
Table 10: Urine Testing - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 32
Table 11: Blood Test Strips - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 34
Table 12: Clinical Chemistry Analyzers Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 36
Table 13: Enzyme Chemistry Reagents Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 38
Table 14: Feces Tests - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 40
Table 15: Substrates Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Table 16: Therapeutic Drug Monitoring Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Table 17: Urine Analysis Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Table 18: Urine Testing - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Table 19: Clinical Chemistry Market, France, Volume (Units), Historic, 2010-2017 50
Table 20: Clinical Chemistry Market, France, Volume (Units), Forecast, 2017-2024 52
Table 21: Blood Test Strips - Rapid Tests & POC Market, France, Volume (Units), Historic, 2010-2017 54
Table 22: Clinical Chemistry Analyzers Market, France, Volume (Units), Historic, 2010-2017 56
Table 23: Enzyme Chemistry Reagents Market, France, Volume (Units), Historic, 2010-2017 58
Table 24: Feces Tests - Rapid Tests & POC Market, France, Volume (Units), Historic, 2010-2017 60
Table 25: Substrates Market, France, Volume (Units), Historic, 2010-2017 62
Table 26: Urine Testing - Rapid Tests & POC Market, France, Volume (Units), Historic, 2010-2017 64
Table 27: Blood Test Strips - Rapid Tests & POC Market, France, Volume (Units), Forecast, 2017-2024 66
Table 28: Clinical Chemistry Analyzers Market, France, Volume (Units), Forecast, 2017-2024 68
Table 29: Enzyme Chemistry Reagents Market, France, Volume (Units), Forecast, 2017-2024 70
Table 30: Feces Tests - Rapid Tests & POC Market, France, Volume (Units), Forecast, 2017-2024 72
Table 31: Substrates Market, France, Volume (Units), Forecast, 2017-2024 74
Table 32: Urine Testing - Rapid Tests & POC Market, France, Volume (Units), Forecast, 2017-2024 76
Table 33: Clinical Chemistry Market, France, Average Price ($) Historic, 2010-2017 77
Table 34: Clinical Chemistry Market, France, Average Price ($), Forecast, 2017-2024 79
Table 35: Clinical Chemistry Market, France, Distribution Share by Revenue ($m), USD Constant, 2016-2017 81
Table 36: Clinical Chemistry Market, France, Company Share by Revenue ($m), USD Constant, 2017 83
Table 37: Clinical Chemistry Market Pipeline Products 87
Table 38: PAI Partners to Acquire ELITech from Ergon Capital Partners 89
Table 39: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 94

1.2 List of Figures
Figure 1: Clinical Chemistry Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 13
Figure 2: Clinical Chemistry Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 15
Figure 3: Blood Test Strips - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 17
Figure 4: Clinical Chemistry Analyzers Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 19
Figure 5: Enzyme Chemistry Reagents Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 21
Figure 6: Feces Tests - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 23
Figure 7: Substrates Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 25
Figure 8: Therapeutic Drug Monitoring Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 27
Figure 9: Urine Analysis Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 29
Figure 10: Urine Testing - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 31
Figure 11: Blood Test Strips - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 33
Figure 12: Clinical Chemistry Analyzers Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 35
Figure 13: Enzyme Chemistry Reagents Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 37
Figure 14: Feces Tests - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 39
Figure 15: Substrates Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 41
Figure 16: Therapeutic Drug Monitoring Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 43
Figure 17: Urine Analysis Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 45
Figure 18: Urine Testing - Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 47
Figure 19: Clinical Chemistry Market, France, Volume (Units), Historic, 2010-2017 49
Figure 20: Clinical Chemistry Market, France, Volume (Units), Forecast, 2017-2024 51
Figure 21: Blood Test Strips - Rapid Tests & POC Market, France, Volume (Units), Historic, 2010-2017 53
Figure 22: Clinical Chemistry Analyzers Market, France, Volume (Units), Historic, 2010-2017 55
Figure 23: Enzyme Chemistry Reagents Market, France, Volume (Units), Historic, 2010-2017 57
Figure 24: Feces Tests - Rapid Tests & POC Market, France, Volume (Units), Historic, 2010-2017 59
Figure 25: Substrates Market, France, Volume (Units), Historic, 2010-2017 61
Figure 26: Urine Testing - Rapid Tests & POC Market, France, Volume (Units), Historic, 2010-2017 63
Figure 27: Blood Test Strips - Rapid Tests & POC Market, France, Volume (Units), Forecast, 2017-2024 65
Figure 28: Clinical Chemistry Analyzers Market, France, Volume (Units), Forecast, 2017-2024 67
Figure 29: Enzyme Chemistry Reagents Market, France, Volume (Units), Forecast, 2017-2024 69
Figure 30: Feces Tests - Rapid Tests & POC Market, France, Volume (Units), Forecast, 2017-2024 71
Figure 31: Substrates Market, France, Volume (Units), Forecast, 2017-2024 73
Figure 32: Urine Testing - Rapid Tests & POC Market, France, Volume (Units), Forecast, 2017-2024 75
Figure 33: Clinical Chemistry Market, France, Company Share (%) 2017 82

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

France Clinical Chemistry Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model